Cargando…

Perioperative bridging anticoagulation for atrial fibrillation—the first randomised controlled trial

ABSTRACT: Patients who have atrial fibrillation (AF) have increased thromboembolic risk. This risk is mitigated through use of anticoagulants, traditionally with vitamin K antagonists such as warfarin, and more recently with drugs such as Xa and thrombin inhibitors. Since anticoagulants increase the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wight, James Matthew, Columb, Malachy Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897904/ https://www.ncbi.nlm.nih.gov/pubmed/27280017 http://dx.doi.org/10.1186/s13741-016-0040-5

Ejemplares similares

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management
por: Shamoun, Fadi, et al.
Publicado: (2015)

Anticoagulants in frail elderly patients with atrial fibrillation: a delicate balance
por: Trinks-Roerdink, Emmy M., et al.
Publicado: (2023)

Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM—CP): a study protocol
por: Adam, Rosalind, et al.
Publicado: (2020)

Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial
por: Clarkesmith, Danielle E., et al.
Publicado: (2013)

Risks of anticoagulation in patients with chronic kidney disease and atrial fibrillation: More than just bleeding?
por: Gutiérrez, Orlando M.
Publicado: (2019)

Considerations Regarding the Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation
por: Reiffel, James A.
Publicado: (2018)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Capsule Commentary on Ashburner et al., Electronic Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation: a Randomized Controlled Trial
por: Mastoris, Ioannis, et al.
Publicado: (2018)

Perioperative interruption of direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta‐analysis
por: Shaw, Joseph R., et al.
Publicado: (2018)

Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery
por: Ge, Yin, et al.
Publicado: (2017)

Perioperative predictors of atrial fibrillation
por: İşcan, Şahin, et al.
Publicado: (2018)

Perioperative interruption of direct oral anticoagulants and vitamin K antagonists in patients with atrial fibrillation: A comparative analysis
por: Shaw, Joseph R., et al.
Publicado: (2020)

Evidence gaps pertaining to high-risk medications: Commentary on anticoagulation in new-onset postoperative atrial fibrillation
por: Akowuah, Enoch, et al.
Publicado: (2022)

A Call for Appropriate Evidence and Outcomes-Based Use and Measurement of Anticoagulation for Atrial Fibrillation: Moving the Population Towards Improved Health Via Multiple Stakeholders
por: Kountz, David S., et al.
Publicado: (2015)

Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery
por: Park, Bo Eun, et al.
Publicado: (2020)

The CRASH trial: the first large-scale, randomised, controlled trial in head injury
por: Roberts, Ian
Publicado: (2001)

Supraneural versus Infraneural Approach to transforaMinal Epidural StEroid injection for unilateral lumbosacral radicular pain (SIAMESE): a study protocol for a randomised non-inferiority trial
por: Galley, Helen F., et al.
Publicado: (2023)

Direct oral anticoagulant use and risk of perioperative bleeding: Evidence of absence or absence of evidence?
por: Lijfering, Willem M., et al.
Publicado: (2018)

Clinical Implications of Recent Trials on Anticoagulation in Patients with Atrial Fibrillation
por: Arya, Arash, et al.
Publicado: (2012)

Protocol for a prospective, international cohort study on the Management and Outcomes of Perioperative Care among European Diabetic Patients (MOPED)
por: Buggy, Donal J, et al.
Publicado: (2021)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Anticoagulation in atrial fibrillation: the present and the future
por: Dweck, Marc R, et al.
Publicado: (2012)

Anticoagulation for atrial fibrillation in active cancer
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Use and Outcomes Associated With Bridging During Anticoagulation Interruptions in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)
por: Steinberg, Benjamin A., et al.
Publicado: (2015)

Bridging case-control studies and randomized trials
por: Rosendaal, Frits R
Publicado: (2001)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

Oral Anticoagulants for Newly Detected Atrial Fibrillation in Cryptogenic Stroke Patients: Still a Bitter Pill to Swallow Quickly
por: Doshi, Rahul N., et al.
Publicado: (2021)

Mitral Regurgitation and Body Mass Index Increase the Predictability of Perioperative Bleeding in Anticoagulated Patients With Nonvalvular Atrial Fibrillation
por: Huang, Hao, et al.
Publicado: (2022)

Atrial fibrillation is not just an artefact in the ICU
por: Seguin, Philippe, et al.
Publicado: (2010)

Commentary: Atrial fibrillation? Go hybrid
por: Moscarelli, Marco, et al.
Publicado: (2021)

Timing of oral anticoagulant therapy in acute ischemic stroke with atrial fibrillation: study protocol for a registry-based randomised controlled trial
por: Åsberg, Signild, et al.
Publicado: (2017)

Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation
por: Smoyer-Tomic, Karen, et al.
Publicado: (2012)

The SARS-CoV-2 effect: an opportunity to reduce general anaesthesia rates for Caesarean section?
por: Dixon, Thomas, et al.
Publicado: (2020)

Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents
por: Bassand, Jean-Pierre
Publicado: (2012)

Patterns of Anticoagulation Use in Patients With Cancer With Atrial Fibrillation and/or Atrial Flutter
por: Fradley, Michael G., et al.
Publicado: (2020)

Commentary: Beyond rhythm control: The increasing appeal of surgical treatment of atrial fibrillation
por: Arghami, Arman, et al.
Publicado: (2021)

Integrated management of atrial fibrillation including tailoring of anticoagulation in primary care: study design of the ALL-IN cluster randomised trial
por: van den Dries, Carline J, et al.
Publicado: (2017)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Atrial Fibrillation Ablation without Interruption of Anticoagulation
por: Santangeli, Pasquale, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lqpddt3sdl104mbnm4h6voff7i